Northwest Biotherapeutics, Inc. (NWBO)
0.1517
0.00 (0.00%)
USD |
OTCM |
Oct 23, 16:00
Northwest Biotherapeutics Market Cap : 253.23M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 253.23M |
| October 22, 2026 | 252.06M |
| October 21, 2026 | 281.61M |
| October 20, 2026 | 274.60M |
| October 19, 2026 | 258.96M |
| October 16, 2026 | 261.25M |
| October 15, 2026 | 258.34M |
| October 14, 2026 | 267.09M |
| October 13, 2026 | 271.24M |
| October 12, 2026 | 270.43M |
| October 09, 2026 | 262.08M |
| October 08, 2026 | 247.06M |
| October 07, 2026 | 247.89M |
| October 06, 2026 | 243.72M |
| October 05, 2026 | 248.39M |
| October 02, 2026 | 256.57M |
| October 01, 2026 | 254.40M |
| September 30, 2026 | 248.56M |
| September 29, 2026 | 249.56M |
| September 28, 2026 | 254.57M |
| September 25, 2026 | 267.09M |
| September 24, 2026 | 266.42M |
| September 23, 2026 | 266.50M |
| September 22, 2026 | 272.10M |
| September 21, 2026 | 278.77M |
| Date | Value |
|---|---|
| September 18, 2026 | 267.25M |
| September 17, 2026 | 276.27M |
| September 16, 2026 | 276.42M |
| September 15, 2026 | 287.29M |
| September 14, 2026 | 275.10M |
| September 11, 2026 | 281.94M |
| September 10, 2026 | 275.85M |
| September 09, 2026 | 282.81M |
| September 08, 2026 | 282.70M |
| September 04, 2026 | 283.20M |
| September 03, 2026 | 283.63M |
| September 02, 2026 | 282.78M |
| September 01, 2026 | 280.44M |
| August 31, 2026 | 284.07M |
| August 28, 2026 | 316.50M |
| August 27, 2026 | 299.04M |
| August 26, 2026 | 288.79M |
| August 25, 2026 | 290.29M |
| August 24, 2026 | 287.92M |
| August 21, 2026 | 283.11M |
| August 20, 2026 | 285.88M |
| August 19, 2026 | 296.38M |
| August 18, 2026 | 300.31M |
| August 17, 2026 | 304.65M |
| August 14, 2026 | 320.51M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PS Ratio | 109.72 |
| Price | 0.1517 |
| Earnings Yield | -16.74% |